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Journal of Cystic Fibrosis 13 (2014) 359–360ESCF Care Guidelines beyond EuropeOver the past two decades there has been a significant
improvement in clinical outcomes for individuals with cystic
fibrosis (CF). The median predicted survival age in the US
reached 41.1 years in 2012 [4]. Although a number of new
medications and more effective therapies have been introduced
to treat CF, improved survival has also been a consequence of
better strategies to use these therapies including: development of
sophisticated patient registries, elaboration and use of evidence-
based best practice guidelines, provision of care by expert,
multidisciplinary care teams and a system-oriented approach to
quality improvement with emphasis on patient-centered and
family-centered care [5].
The updated European CF Society (ECFS) Standards of Care
Guidelines presented in the accompanying supplement of the
Journal of Cystic Fibrosis provide another opportunity to
improve the quality of care for individuals with CF and to
establish best practice standards across Europe [1–3]. These care
guidelines also represent a significant contribution for improving
CF care worldwide. The ECFS has not only provided
recommendations for the specific care practices and therapeutic
interventions, but they strive to define best practices for the
delivery of expert, multidisciplinary care within specialized care
centers. However, adoption and implementation of these care
guidelines may be challenging for some countries in Europe [6],
Latin America, and other areas of the world [7] where resources
are limited. Therapeutic programs must be adapted to specific
geographical, social and political environments where poverty,
lack of understanding of the value of multidisciplinary care and
geographic barriers can hinder access to CF care. Nevertheless,
centralization and organization of CF care within centers of
excellence employing best practices and engaging in quality
improvement initiatives, and the creation of national data
registries represent important steps that can lead to improved
survival. Gutierrez et al. [7] suggested that the key to improve CF
outcomes in Latin America is enhancing expertise and access to
specialized CF care. Similarly, Colombo and Littlewood [6]
suggested that European countries should have at least one
adequately staffed CF care center, improved funding, neonatal
screening, national patient registries and the formation of national
CF parent and patient organizations.
The development of a care center network in the United States
has been instrumental in advancing care practices and improving016/j.jcf.2014.05.002
uropean Cystic Fibrosis Society. Published by Elsevier B.V. Athe lives of those with CF [8]. However, to successfully implement
care guidelines with high standards in many areas of the world the
current framework of CF care delivery will need to be transformed
because there is a lack of expert manpower and multidisciplinary
teams. For example, in Latin America there are several barriers to
establishing comprehensive multidisciplinary CF centers. First,
there are few pediatric pulmonologists who have received training
at high-performing CF centers abroad. Additionally, the structure
of academic medicine, including time commitment and poor
remuneration, makes it very difficult for these individuals to
serve as mentors and leaders in CF care. Most academic faculty
appointments and governmental and charitable job opportuni-
ties do not allow financial independence with physicians and
other healthcare professionals in these settings are forced to
supplement their income byworking part-time in private practice.
This makes it impossible to support a multidisciplinary team and
effectively creates a choice of care for their patients, preventing
CF care providers from caring for an adequate minimal number
of patients. In Chile, the majority of the population receives
health care through public health service bureaus [9]. These
bureaus are required to be self-sufficient and able to handle all but
the most complex medical conditions (such as transplantation and
complex neonatal care). Thus, CF is managed within each bureau,
resulting in a significant dispersion of patients. In Chile's capital
Santiago, a city of 6.5 million inhabitants, the six health bureaus
each care for an average of 20–30 patients, an insufficient number
for providers to acquire needed expertise. The ECFS Center
Framework Guidelines call for 50 patients as the minimum number
to maintain an appropriate level of expertise and experience [1].
Nonetheless, there are examples of CF care centers in Latin
America, specifically in Argentina [10] and Brazil [11], that fulfill
the requirements proposed by the ECFS. However, these are
typically single, local care centers, led by a visionary leader and
dedicated personnel, without translation into regional or national
programs.
An additional value of care guidelines is that they can be
used to guide quality improvement efforts. To be successful,
reliable information must be available to track both therapeutic
interventions and outcomes. Therefore, the development of
patient registries to track these data is essential for optimal CF care.
Some countries in South America attempted developing such
registries (Cystic Fibrosis Latin American Registry, REGLAFQ,ll rights reserved.
360 Editorial1987–2000); but they have been limited in scope, reach, provider
participation and many are not currently active. Brazil, with a
population of 190 million, more than 3000 individuals with CF
and 250 to 300 newly diagnosed patients yearly, has made
important advances in developing a CF center network currently
with thirteen centers, neonatal screening in several provinces as
part of the National Neonatal Registry Program (Programa
Nacional de Triagem Neonatal, PNTN), and a patient registry
(Registro Brasileiro de Fibrose Cistica, REBRAFQ) [11]. Chile has
made significant progress since 2002 with the start of the National
Cystic Fibrosis Program (Programa Nacional de Fibrosis Quistica,
PNFQ) [12]. Lastly, Argentina with a comparatively high
incidence of CF, has reinitiated the Argentinian Cystic Fibrosis
Registry, RENAFQ, with currently 790 entries (S. Pereyro,
personal communication).
The revised ECFS Care Guidelines provide a roadmap to
enhancing care in Europe. Hopefully, these guidelines will inspire
the development of specialized centers that can provide expert,
multi-disciplinary care throughout the world.References
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